MedTrace Logo

Glucose Monitoring During Chemotherapy

NCT04473378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2025-01-10

No results posted yet for this study

Summary

This is a research study to look at blood sugar changes during chemotherapy using a continuous blood sugar monitoring device. The device uses patches that attach to the skin on the back of the arm to measure blood sugar changes for the duration of the chemotherapy course. Each patch lasts for about 2-weeks. During chemotherapy visits, new patches will be placed and will be worn until the chemotherapy course is complete. Participants will be in this study for 6 months. Approximately 50 patients will be enrolled in this study.

Conditions

Interventions

DEVICE

FreeStyle Libre Pro

The device uses patches that attach to the skin on the back of the arm to measure blood sugar changes for the duration of the chemotherapy course.

Sponsors & Collaborators

Principal Investigators

  • Melissa Accordino, MD · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-31
Primary Completion
2022-08-01
Completion
2022-08-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04473378 on ClinicalTrials.gov